Angiotensin Receptor-Neprilysin Inhibition Therapy and Improved Exercise Parameters in Heart Failure with Reduced Ejection Fraction

被引：2
|
作者：
Schwartzmann, Pedro [1 ]
机构：
[1] Hosp Unimed Ribeirao Preto, Ribeirao Preto, SP, Brazil
来源：
ARQUIVOS BRASILEIROS DE CARDIOLOGIA | 2020年 / 115卷 / 05期
关键词：
Heart Failure; Stroke Volume; Fatigue; Mortality; Morbidity; Prognosis; Exercise; Intolerance;
D O I：
10.36660/abc.20200566
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：828 / 829
页数：2
相关论文
共 50 条
  • [1] Angiotensin Receptor-Neprilysin Inhibition in Heart Failure With Reduced Ejection Fraction A Paradigm for All?
    Konstam, Marvin A.
    JACC-HEART FAILURE, 2016, 4 (10) : 823 - 825
  • [2] Angiotensin Receptor-Neprilysin Inhibition (ARNI) Therapy and Reverse Remodeling in Heart Failure With Reduced Ejection Fraction
    Drazner, Mark H.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2019, 322 (11): : 1051 - 1053
  • [3] Angiotensin receptor-neprilysin inhibition and improved ventricular-arterial coupling in heart failure with reduced ejection fraction
    Stegmann, Tina
    Parentin, Luisa
    Schirmer, Stephan H.
    Lavall, Philipp
    Hagendorff, Andreas
    Laufs, Ulrich
    Lavall, Daniel
    AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2024, 327 (06): : H1477 - H1489
  • [4] Angiotensin Receptor-neprilysin Inhibitor Therapy is Associated With Improved Echocardiographic Parameters in Chronic Heart Failure Patients With Reduced Ejection Fraction
    Poglajen, Gregor
    Drofenik, Ajda Anzic
    Jurca, Dominika
    Zemljic, Gregor
    Cerar, Andraz
    Okrajsek, Renata
    Sebestjen, Miran
    Frljak, Sabina
    Vrtovec, Bojan
    CIRCULATION, 2019, 140
  • [5] Angiotensin receptor-neprilysin inhibitor adherence and outcomes in heart failure with reduced ejection fraction
    Cho, Dong-Hyuk
    Choi, Jimi
    Youn, Jong-Chan
    Kim, Mi-Na
    Lee, Chan Joo
    Son, Jung-Woo
    Yoo, Byung-Su
    ESC HEART FAILURE, 2025, 12 (01): : 603 - 612
  • [6] Angiotensin receptor-neprilysin inhibitors: A new paradigm in heart failure with reduced ejection fraction
    Docherty, Kieran F.
    McMurray, John J. V.
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2019, 281 : 179 - 185
  • [7] Impact of angiotensin receptor-neprilysin inhibition on vascular function in heart failure with reduced ejection fraction: A pilot study
    Nathaniel, Sangeetha
    McGinty, Shane
    Witman, Melissa A. H.
    Edwards, David G.
    Farquhar, William B.
    Hosmane, Vinay
    Wenner, Megan M.
    PHYSIOLOGICAL REPORTS, 2022, 10 (05):
  • [8] Benefits of Angiotensin Receptor-Neprilysin Inhibitor in Heart Failure with Reduced Ejection Fraction: A Longitudinal Study
    Jain, Dharmendra
    Pandey, Umesh Kumar
    Tripathi, Suyash
    Kaushley, Abhishek
    Verma, Bhupendra
    Ghosh, Soumik
    Santosh, Krishna Vemuri
    Prajapati, Rajpal
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2022, 16 (04) : EC17 - EC22
  • [9] Association Between Angiotensin Receptor-Neprilysin Inhibition, Cardiovascular Biomarkers, and Cardiac Remodeling in Heart Failure With Reduced Ejection Fraction
    Murphy, Sean P.
    Prescott, Margaret F.
    Maisel, Alan S.
    Butler, Javed
    Pina, Ileana L.
    Felker, G. Michael
    Ward, Jonathan H.
    Williamson, Kristin M.
    Camacho, Alexander
    Kandanelly, Ritvik R.
    Solomon, Scott D.
    Januzzi, James L.
    CIRCULATION-HEART FAILURE, 2021, 14 (06) : E008410
  • [10] ASSOCIATION BETWEEN ANGIOTENSIN RECEPTOR-NEPRILYSIN INHIBITION, CARDIOVASCULAR BIOMARKERS AND CARDIAC REMODELING IN HEART FAILURE WITH REDUCED EJECTION FRACTION
    Murphy, Sean P.
    Prescott, Margaret
    Maisel, Alan
    Butler, Javed
    Pina, Ileana
    Felker, G. Michael
    Ward, Jonathan
    Williamson, Kristin
    Camacho, Alex
    Kandanelly, Ritvik
    Solomon, Scott
    Januzzi, James
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (18) : 610 - 610
12345